☆ 4.6 Article

Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment

EJSO (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?

Giacomo Montagna et al.

Summary: In cN1 patients rendered cN0 with neoadjuvant chemotherapy, when >= 3 sentinel lymph nodes (SLNs) are removed, the clipped node is an SLN in the majority of cases. Failure to retrieve the clipped node should not be an indication for axillary lymph node dissection (ALND).

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization

James Sun et al.

Summary: Radar reflector localization (RRL)-guided targeted axillary dissection (TAD) after neoadjuvant chemotherapy (NAC) is a safe and feasible approach for assessing nodal involvement in breast cancer patients, confirming the excision of positive axillary nodes, and reducing false-negative rates.

CLINICAL BREAST CANCER (2021)

添加到收藏夹

Article Oncology

Omission of Axillary Lymph Node Dissection is Associated with Inferior Survival in Breast Cancer Patients with Residual N1 Nodal Disease Following Neoadjuvant Chemotherapy

Muayad F. Almahariq et al.

Summary: The study compared the survival outcomes of breast cancer patients with residual lymph node disease who underwent sentinel lymph node dissection (SLND) or axillary lymph node dissection (ALND) using the National Cancer Database (NCDB). The results showed that SLND was associated with lower survival rates compared to ALND in matched cohorts, suggesting that ALND may be preferred over SLND for patients with residual lymph node disease. Further prospective trials are needed to confirm the efficacy of SLND in this patient population.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer

Stephanie M. Wong et al.

Summary: This study demonstrates that sentinel lymph node biopsy alone for patients who convert to pathologic node-negativity after neoadjuvant chemotherapy is associated with low short-term axillary recurrence rates. Additional follow-up data from prospective clinical trials are needed to confirm long-term oncologic safety and optimal local therapy recommendations.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer

Olga Kantor et al.

Summary: For patients selected for NET, over 90% of cN0 patients have fewer than three positive nodes at surgery. There was no survival difference between SLNB and ALND in the DFBWCC cohort, indicating an opportunity to de-escalate axillary treatment in patients with limited residual nodal disease.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up

Sabrina Kahler-Ribeiro-Fontana et al.

Summary: This study evaluated the outcomes of patients undergoing NAT who remained or converted to cN0 and received SNB, showing a high overall survival rate after 10-year follow-up. The use of standard SNB in cN1/2 patients who become cN0 after NAT was deemed acceptable and did not result in worse outcomes.

EJSO (2021)

添加到收藏夹

Article Oncology

Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments

Antonio Esgueva et al.

Summary: This study demonstrates that achieving a pathologic complete response is beneficial for breast conservative surgery and sentinel lymph node biopsy. In selected subgroups, avoiding any axillary surgery after neoadjuvant treatment may be feasible. In cN+ patients, any pathologic complete response is associated with improved survival.

JOURNAL OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer

Antonio Mariscal Martinez et al.

Summary: The use of magnetic seeds for preoperative localization and surgical dissection of metastatic axillary lymph nodes in breast cancer patients after neoadjuvant chemotherapy is safe and effective with a success rate of 100%. Additionally, targeted axillary dissection (TAD) reduces the rate of false negatives associated with sentinel lymph node biopsy alone.

SURGICAL ONCOLOGY-OXFORD (2021)

添加到收藏夹

Article Oncology

Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event

Andrea Barrio et al.

Summary: This study examined nodal recurrence rates in patients with clinically node-positive cancer treated with sentinel lymph node biopsy after neoadjuvant chemotherapy, showing low rates of axillary failure at a median follow-up of 40 months, supporting potential omission of axillary lymph node dissection in patients achieving nodal pathologic complete response with SLNB alone.

JAMA ONCOLOGY (2021)

添加到收藏夹

Review Oncology

The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis

Parinita K. Swarnkar et al.

Summary: The study demonstrates that using Marked Lymph Node Biopsy and Targeted Axillary Dissection surgery procedures can safely replace more radical surgery in breast cancer patients, accurately assessing the lymph node status. These procedures can improve patients' quality of life and reduce complications.

CANCERS (2021)

添加到收藏夹

Article Oncology

Predictive factors for omitting lymphadenectomy in patients with node-positive breast cancer treated with neo-adjuvant systemic therapy

Sergi Fernandez-Gonzalez et al.

BREAST JOURNAL (2020)

添加到收藏夹

Article Oncology

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer

Olga Kantor et al.

NPJ BREAST CANCER (2020)

添加到收藏夹

Article Surgery

Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer

Marios Konstantinos Tasoulis et al.

JAMA SURGERY (2020)

添加到收藏夹

Article Oncology

Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node

Rupa Patel et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

Jean-Marc Classe et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

添加到收藏夹

Article Medicine, General & Internal

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

G. von Minckwitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Oncology

Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?

Tracy-Ann Moo et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy

Steffi Hartmann et al.

EJSO (2018)

添加到收藏夹

Article Oncology

Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment

Christian Siso et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

N. Masuda et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

添加到收藏夹

Article Surgery

Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery

Audree B. Tadros et al.

JAMA SURGERY (2017)

添加到收藏夹

Article Oncology

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

U. A. Nitz et al.

ANNALS OF ONCOLOGY (2017)

添加到收藏夹

Review Surgery

Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients

Hiba El Hage Chehade et al.

AMERICAN JOURNAL OF SURGERY (2016)

添加到收藏夹

Article Oncology

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

Abigail S. Caudle et al.

JOURNAL OF CLINICAL ONCOLOGY (2016)

添加到收藏夹

Article Surgery

Marking Axillary Lymph Nodes With Radioactive Iodine Seeds for Axillary Staging After Neoadjuvant Systemic Treatment in Breast Cancer Patients The MARI Procedure

Mila Donker et al.

ANNALS OF SURGERY (2015)

添加到收藏夹

Article Oncology

Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study

Jean-Francois Boileau et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Article Medicine, General & Internal

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer The ACOSOG Z1071 (Alliance) Clinical Trial

Judy C. Boughey et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Oncology

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis

Tracey DiSipio et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Evaluation of a hydrogel based breast biopsy marker (HydroMARK®) as an alternative to wire and radioactive seed localization for non-palpable breast lesions

Rebecca L. Klein et al.

JOURNAL OF SURGICAL ONCOLOGY (2012)

添加到收藏夹

Article Oncology

Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer

Laura S. Dominici et al.

CANCER (2010)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: In vitro sonographic study

Deepak G. Bedi et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.